CMS sanctioned Cigna Jan. 21, 2016, after an audit found the payer failed to comply with CMS’ Medicare Part C and Part D requirements. As a result, members experienced delays or denials in medical services and prescription drugs. CMS’ audit also revealed the deficiencies increased out-of-pocket expenses for some policyholders.
CMS’ clearance means Cigna can resume selling its Medicare prescription drug plans immediately, with coverage beginning July 1.
More articles on payer issues:
Cleveland Clinic, Oscar Health to offer co-branded health plan
Centene to enter ACA exchanges in 3 states
BCBS of Louisiana names CMO
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
